Truman B. Grayson's research while affiliated with University of Alabama at Birmingham and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (16)
Thioredoxin-interacting protein (Txnip) has emerged as a key factor in pancreatic beta cell biology and its upregulation by glucose and diabetes contributes to the impairment in functional beta cell mass and glucose homeostasis. In addition, beta cell deletion of Txnip protects against diabetes in different mouse models. However, while Txnip is ubi...
Endoplasmic reticulum (ER) stress contributes to pancreatic beta cell apoptosis in diabetes, but the factors involved are still not fully elucidated. Growth differentiation factor 15 (GDF15) is a stress response gene and has been reported to be increased and play an important role in various diseases. However, the role of GDF15 in beta cells in the...
Currently, no oral medications are available for type 1 diabetes (T1D). While our recent randomized placebo-controlled T1D trial revealed that oral verapamil had short-term beneficial effects, their duration and underlying mechanisms remained elusive. Now, our global T1D serum proteomics analysis identified chromogranin A (CHGA), a T1D-autoantigen,...
Here, Thielen et al. show that a newly designed, orally available small molecule inhibited pancreatic islet TXNIP expression, glucagon secretion, hepatic glucagon action, glucose production, and steatosis, and exhibited strong anti-diabetic effects in mouse models of type 1 and type 2 diabetes, promising a distinct and innovative diabetes treatment...
Endoplasmic reticulum (ER) stress has been shown to play an important role in beta cell loss in diabetes. However, the factors involved in this process are still not fully understood. Growth differentiation factor 15 (GDF15), a member of the transforming growth factor beta (TGFβ) family, is a stress response gene and is involved in various diseases...
Pancreatic beta-cell death is a major factor in the pathogenesis of type 1 diabetes (T1D), but straightforward methods to measure beta-cell loss in humans are lacking underlining the need for novel biomarkers. Using studies in INS-1 cells, human islets, diabetic mice and serum samples of subjects with T1D at different stages, we have identified ser...
Pancreatic beta cell loss is a key factor in the pathogenesis of type 1 diabetes (T1D), but therapies to halt this process are lacking. We previously reported that the approved antihypertensive calcium-channel blocker verapamil, by decreasing the expression of thioredoxin-interacting protein, promotes the survival of insulin-producing beta cells an...
Glucagon-like peptide 1 receptor (GLP-1R) is a G protein-coupled receptor that is highly expressed on pancreatic beta-cells and activated by endogenous incretins or antidiabetic GLP-1R agonist drugs. GLP-1R function is important in maintaining glucose homeostasis and involves stimulation of glucose-induced beta-cell insulin secretion via cAMP gener...
Loss of functional beta cell mass represents a major factor in the pathogenesis of diabetes. Currently, there are no therapies that halt this process; however, thioredoxin-interacting protein (TXNIP) has recently emerged as a promising therapeutic target. TXNIP was found to be the top glucose-induced gene in a human pancreatic islet microarray, is...
Glucagon-like peptide 1 receptor (GLP1R) agonists are widely used to treat diabetes. However, their function is dependent on adequate GLP1R expression, which is downregulated in diabetes. GLP1R is highly expressed on pancreatic beta cells and activation by endogenous incretin or GLP1R agonists increases cAMP generation, which stimulates glucose-ind...
Endoplasmic reticulum (ER) stress plays an important role in the pathogenesis of diabetes and the associated beta cell apoptosis. Although microRNAs have been widely studied in various diseases including diabetes, the role of microRNAs in ER stress and beta cell apoptosis has only started to be elucidated. We recently showed that diabetes increases...
Thioredoxin-interacting protein (TXNIP) is a key regulator of diabetic β-cell apoptosis and dysfunction and TXNIP inhibition prevents diabetes in mouse models of type 1 and type 2 diabetes. While we have previously shown that TXNIP is strongly induced by glucose, any regulation by the pro-inflammatory cytokines tumor necrosis factor α (TNFα), inter...
Citations
... These sites are located at or near CpG islands and other regulatory regions (Table 1). Thus, variations in their methylation may be linked to altered expression of genes that contribute to lipid metabolism, hyperglycemia, and inflammation (Jones et al., 2021;Lu et al., 2022). While studies are limited, MR for methylation and cardiometabolic traits suggest that altered methylation is the consequence, not the cause, of metabolic dysfunction (Dekkers et al., 2016;Sayols-Baixeras et al., 2018;Zaghlool et al., 2018). ...
... Similarly, we found an increase in the level of GDF15 prior to T1D onset. There is also an increase of GDF15 expression in β cells under endoplasmic reticulum stress conditions [47]. However, the level of GDF15 in pancreatic islets is reduced in NOD mice with insulitis and depleted in humans with T1D [13]. ...
... Verapamil treatment slowed the progression of diabetes, improved pancreatic beta-cell function and thus contributed to decreasing insulin requirements for 2 years. The beneficial effect of verapamil disappeared when the treatment was stopped [7]. In 2023, Gregory P Forlenza from the United States and his research group emphasized the experimental evidence suggesting that the over-expression of thioredoxin-interacting protein leads apoptosis and death of beta cell in the pancreas. ...
... QotM #4 focused on a search for the molecular target of a novel small molecule that has demonstrated efficacy in murine models of diabetes, with an added benefit of improving fatty liver [23]. The specific question was: "What is the molecular target of an anti-diabetic small molecule?" ...
... Serum miRNA-204 was increased in children with T1D, but not in those with type-2 diabetes, and was inversely correlated with cell functioning. Therefore, it could serve as a novel biomarker for T1D-associated β-cell damage (35). ...
... The last two modifications are considered irreversible [86,87]. The formation of sulfenic acid is recorded in proteins involved in the regulation of apoptosis, activation, and proliferation of immune cells [89][90][91]. Sulfene groups have also been identified in the catalytic sites of some enzymes, including peroxiredoxins (Prx), NADH peroxidase, and others [86,87,92]. It is known that cysteine residues in the molecules of some transcription factors (for example, NF-kB, Fos and Jun) and proteins involved in intracellular signaling and metabolism (for example, glyceraldehyde-3-phosphate dehydrogenase (GPDH), glutathione reductase (GR), proteine tyrosine phosphatase (PTP), kinases and proteases), can be oxidized to sulfene groups under conditions in vitro [87]. ...
Reference: The Redox-Catalytic Properties of Cobalamins
... It is worth mentioning here that at this time other drugs that modulate insulin exocytosis to protect β-cells are upstream of SNARES. For example, Sulfonylureas (chlorpropamide, glipizide, etc.) increase insulin secretion via binding to ATP-dependent K + channel [1,194]; GLP-1 agonists (liraglutide, exenatide) boost insulin secretion via binding to GLIP-1 receptor in the β-cell [1,195]; and additionally, inhibitors of Thioredoxin-interacting protein (TXNIP), promote insulin production and GLP-1 signaling via regulation of microRNA, are emerging as a potential treatment option for diabetes [196,197]. However, since all of these abovementioned drugs work upstream of SNAREs, there may be effects beyond the distal steps of insulin exocytosis, again implying the significance of developing drugs for specific modulations of SNARE and SNARE regulatory proteins in the β-cell. ...
... Understanding the role of miR-204-5p is however more complex. While in 3 different studies overexpression in human islets showed increased apoptosis, reduced insulin secretion, and decreased expression of glucagon-like peptide 1 (GLP-1) receptors (25,31,32), a more recent human islet study neither validate the gene targets nor confirm the reduction in insulin secretion (33). Within the group of miRNAs differentially expressed in T2D islets and involved in the regulation of insulin secretion, we found increased expression of miR-187-3p, miR-124-3p, miR-463-3p, miR-130a-3p, miR-130b-3p, miR-152-3p, and miR-200c-3p (34-38) to be involved in β-cell dysfunction, while decreased expression of miR-7-5p (miR-7a; (39)) seems to be a mechanism by which this miRNA exerts a compensatory regulatory effect on exocytosis (Fig. 2). ...
Reference: miRNAs in the Beta Cell-Friends or Foes?
... 24 It has been demonstrated that miR-204 activates the unfolded protein response signaling, promoting endoplasmic reticulum stress and apoptosis in b-cell lines and human islets. 52 ...
... In contrast, some gene groups were conversely expressed in NOD and db/db + mSTZ analyses. For example, NOD group T1-down3, containing some genes involved in adaptive stress response (Txnip and Herpud1) 33,111 , was, in addition to healthy cells, also highly expressed in db/db and mSTZ model cells. ...